BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 18190550)

  • 21. Recurrence of autoimmune disease, primary sclerosing cholangitis, primary biliary cirrhosis, and autoimmune hepatitis after liver transplantation.
    Duclos-Vallee JC; Sebagh M
    Liver Transpl; 2009 Nov; 15 Suppl 2():S25-34. PubMed ID: 19876939
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Liver disease recurrence after liver transplantation].
    Rakela B J
    Rev Med Chil; 2010 Apr; 138(4):504-10. PubMed ID: 20668801
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histologic characteristics of late cellular rejection, significance of centrilobular injury, and long-term outcome in pediatric liver transplant recipients.
    Sundaram SS; Melin-Aldana H; Neighbors K; Alonso EM
    Liver Transpl; 2006 Jan; 12(1):58-64. PubMed ID: 16382471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liver transplantation in autoimmune liver disease--selection of patients.
    Tillmann HL; Jäckel E; Manns MP
    Hepatogastroenterology; 1999; 46(30):3053-9. PubMed ID: 10626159
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recurrence of diseases following orthotopic liver transplantation.
    Kotlyar DS; Campbell MS; Reddy KR
    Am J Gastroenterol; 2006 Jun; 101(6):1370-8. PubMed ID: 16771963
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liver transplantation in children with metabolic diseases: the studies of pediatric liver transplantation experience.
    Arnon R; Kerkar N; Davis MK; Anand R; Yin W; González-Peralta RP;
    Pediatr Transplant; 2010 Sep; 14(6):796-805. PubMed ID: 20557477
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term outcome of liver transplantation in patients with PSC: a comparative analysis with PBC.
    Maheshwari A; Yoo HY; Thuluvath PJ
    Am J Gastroenterol; 2004 Mar; 99(3):538-42. PubMed ID: 15056099
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recurrent primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis after transplantation.
    Faust TW
    Liver Transpl; 2001 Nov; 7(11 Suppl 1):S99-108. PubMed ID: 11689782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A re-evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts.
    Alabraba E; Nightingale P; Gunson B; Hubscher S; Olliff S; Mirza D; Neuberger J
    Liver Transpl; 2009 Mar; 15(3):330-40. PubMed ID: 19243003
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence, timing, and risk factors for acute and chronic rejection.
    Neuberger J
    Liver Transpl Surg; 1999 Jul; 5(4 Suppl 1):S30-6. PubMed ID: 10431015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-compliance in children post-liver transplant. Who are the culprits?
    Falkenstein K; Flynn L; Kirkpatrick B; Casa-Melley A; Dunn S
    Pediatr Transplant; 2004 Jun; 8(3):233-6. PubMed ID: 15176959
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liver transplantation for Echinococcus granulosus hydatid disease.
    Moreno-González E; Loinaz Segurola C; García Ureña MA; García García I; Gómez Sanz R; Jiménez Romero C; González Pinto I; Corral Sanchez MA; Palma Carazo F
    Transplantation; 1994 Oct; 58(7):797-800. PubMed ID: 7940713
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcomes after liver transplantation in young infants.
    Sundaram SS; Alonso EM; Anand R;
    J Pediatr Gastroenterol Nutr; 2008 Oct; 47(4):486-92. PubMed ID: 18852642
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liver transplantation in autoimmune liver diseases.
    Ilyas JA; O'Mahony CA; Vierling JM
    Best Pract Res Clin Gastroenterol; 2011 Dec; 25(6):765-82. PubMed ID: 22117641
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of acute rejection episodes on long-term renal allograft survival.
    Wu J; Chen J; Wang Y; Zhang J; Zhu Z; Shou Z; Wang S; Zhang P; Huang H; He Q
    Chin Med J (Engl); 2003 Nov; 116(11):1741-5. PubMed ID: 14642149
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Late hepatic allograft dysfunction.
    Wiesner RH; Menon KV
    Liver Transpl; 2001 Nov; 7(11 Suppl 1):S60-73. PubMed ID: 11689778
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Equal overall rejection rate in pre-transplant flow-cytometric cross-match negative and positive adult recipients in liver transplantation.
    Matinlauri IH; Höckerstedt KA; Isoniemi HM
    Clin Transplant; 2005 Oct; 19(5):626-31. PubMed ID: 16146554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute hepatic allograft rejection: incidence, risk factors, and impact on outcome.
    Wiesner RH; Demetris AJ; Belle SH; Seaberg EC; Lake JR; Zetterman RK; Everhart J; Detre KM
    Hepatology; 1998 Sep; 28(3):638-45. PubMed ID: 9731552
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adolescent non-adherence: prevalence and consequences in liver transplant recipients.
    Berquist RK; Berquist WE; Esquivel CO; Cox KL; Wayman KI; Litt IF
    Pediatr Transplant; 2006 May; 10(3):304-10. PubMed ID: 16677353
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Frequent overlap of active hepatitis in recurrent primary sclerosing cholangitis after living-donor liver transplantation relates to its rapidly progressive course.
    Miyagawa-Hayashino A; Egawa H; Yoshizawa A; Ueda Y; Ichida T; Ueno Y; Uemoto S; Harada K; Nakanuma Y
    Hum Pathol; 2011 Sep; 42(9):1329-36. PubMed ID: 21334714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.